缺血性卒中预防中的氯吡格雷抵抗及其应对措施  

Clopidogrel resistance and its countermeasures in the prevention of ischemic stroke

作　　者：张江山[1] 李振光[1] 张金彪[1] 孙超[1] 

机构地区：[1]威海市立医院神经内科,264200

出　　处：《国际脑血管病杂志》2015年第4期274-280,共7页International Journal of Cerebrovascular Diseases

摘　　要：氯吡格雷治疗可抑制血小板聚集，降低卒中复发风险，但对不同人群的血小板抑制作用存在较大差异。文章对缺血性卒中预防中的氯吡格雷抵抗机制及其应对措施进行了综述。Clopidogrel can intubit platelet aggregation and reduce the risk of recurrent stroke. However, it is a great difference ha antiplatelet inhibition in different populations. This article reviews the mechanism of clopidogel resistance and its countermeasures in the prevention of ischemic stroke.

关 键 词：卒中 脑缺血 氯吡格雷 抗药性 抗血小板聚集药 危险因素 

分 类 号：R743.3[医药卫生—神经病学与精神病学]